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The mechanism of action of one cIass of sodium channel opening agents (batrachotoxinin, veratridine, 
aconitine and grayanotoxin) is proposed to involve complexation of a triad of agent oxygen atoms with 
the E-ammonium ion of a channel lysing side chain, holding open the mouth or exit of the ion channel. 
This idea complements the oxygen triad model derived by structural considerations (Masutani, T., 
Seyama, I., Narahashi, T. and Iwasa, J. (1981) J. Pharm. Exp. Therap. 217,812) and extended by crystal 
structure comparisons (Codding, P.W. (1983) J. Am. Chem. Sot. 105,3172). The mechanism is based on 
results for a~tylcholine receptor ion channel gating, structure and function, using single group rotation 
(SGR) theory (cf. Kosower, E.M. (1983) Biochem. Biophys. Res. Commun. 111, 1022 and in press (1983); 
. FEBS Lett. (1983) 155, 245; ibid. 157, 144; Biophys. J. (1983) 45, in press). 
1. INTRODUCTION 
Channel ope&ng toxins can be divided into two 
classes: (A) alkaloids and ter~noids; (B) small 
polypeptides. Class A includes one of the most tox- 
ic small molecules known to man, the active princi- 
ple of a South American frog exudate, 
batrachotoxin [1,2], as well as grayanotoxin I, 
aconitine (the toxic agent derived from the plant, 
monkshood) and veratridine. Ciass B contains the 
pol~eptides derived from scorpion and sea 
anemone toxins. It is always of interest to search 
for possible common features in materials with 
similar biological actions. 
Single group rotation (SGR) theory (an ex- 
amination of the biological consequences of a 
minimal conformational change) led to a model 
for the binding of acetylcholine (ACh) to the 
acetylcholine receptor (AChR) and for the gating 
and structure of the AChR ion channel [3]. One of 
the important predictions of SGR theory applied 
to the AChR was that there would be a particular 
amino acid sequence for the ion-carrying portion 
of the ion channel: lys(l), glu(4), lys(8), glu(l1). . . 
along an a-helical segment of protein. After the 
complete amino acid sequences for the AChR were 
published 14-81, the predicted sequence was iden- 
tified in the a-subunit of the AChR. The theory led 
to the selection of 7 ion channel elements among 
all of the subunits, and the construction of a struc- 
tural model for the bilayer portion of the AChR, 
accounting for about 25% of the 2333 amino acids 
in the receptor and including a binding site, a 
gating mechanism and an ion channel [g-12]. SGR 
theory has been used to model a further 25% of the 
AChR [13]. It was proposed [3] that the motion of 
a lysine out of the channel should accompany ac- 
tivation (‘gating’) of the channel, and that similar 
features might be found in other channels, e.g., the 
sodium channel. It was thus logical to search for a 
mechanism by which channel opening molecules 
could assist in keeping lysine out of the ion 
channel. 
2. THEORY AND DISCUSSION 
We would like to propose that class A molecules 
open the channel by interacting with the c”- 
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ammonium group of lysine at the entry or exit. A 
negative charge (glutamate or aspartate, the ‘exo- 
channel anion’) is expected to be present near the 
entry or exit to the channel as a binding site for the 
lysine ammonium ion. The proposal can be refor- 
mulated as a set of questions: 
(i) Do toxin molecules contain groups capable of 
holding the e-ammonium ion out of the ion 
channel? 
(ii) Do the toxin molecules carry groups which 
might interact with the glu or asp ‘exo-channel 
anion’? 
To answer the first question, I turned to the 
finding in [14] and [15] that an ammonium ion is 
complex particularly well by a triad of oxygens in 
an appropriate geometric arrangement. I searched 
for and discovered this structural feature in the 
class A channel-opening toxins. For each type of 
class A molecule, crystal structures of closely 
related compounds show that a triad of oxygens is 
present. In addition, there are other groups in the 
toxin molecule (protonated nitrogen or hydroxyl) 
suitable for hydrogen-bonding to an anion. 
The structure and oxygen triad for batrachotox- 
in (BTX) (1) are illustrated in fig.1 together with 
the crystal structure for a p-bromobenzoate [161. It 
should be noted that BTX incorporates a 
2k-2,4-dimethylpyrrole-3-carboxylate group but 
that the 20cu-benzoate ster is just as potent 
physiologically as natural BTX [17]. A schematic 
model of how BTX or other oxygen triad toxins 
can favor open channels rather than closed chan- 
nels is shown in fig.2. A preliminary account of 
our mechanistic analysis has been presented in 
[18]. Proximity of the combined BTX to the chan- 
nel entry might inhibit approach of ions; a low 
conductance is found for the BTX-opened channel 
[19,20]. 
The oxygen triad idea was developed in- 
dependently in [21] for grayanotoxin (GTX) 
derivatives. The crystal structure studies for GTX 
II [22] may be used as a guide to the relative posi- 
tions of the oxygen-containing groups in GTX. 
The extensive set of derivatives studied in [21] 
allows us to accept their conclusion that the pro- 
bable oxygen triad in GTX derivatives consists of 
the 3,&, 5,8 and Sp OH groups. 
The second question, concerning toxin groups 
which might interact with the exo-channel anion, 
can be answered in the affirmative. The 14 and 15 
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Fig.1. The structural formula for batrachotoxin 
20cu-2,4-dimethylpyrrole-3-carboxylate @TX) (1) 
together with a crystal structure for batrachotoxin p-
bromobenzoate. The triad oxygens are starred in both 
the molecular formula and the crystal structure. A 
partial structure of BTX at the lower left shows the triad 
oxygen clearly. 
OH groups of GTX should be suitable for binding 
to a polar group, serving a function similar to that 
of the nitrogens in BTX and veratridine (V). The 
protonated nitrogens of BTX and V are excellent 
groups for binding to an exo-channel anion at the 
entry (or exit) to the channel. 
Channel 
r-’ 
+ ,,- -’ I 
w,q Channel 
!-i!? closed 
Fig.2. A schematic representation f the relationship 
between the channel e-ammonium group of lysine and an 
oxygen triad toxin (in this case, BTX) associated with the 
protein near the mouth (or exit) of the channel. 
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The idea that an oxygen triad is important in the 
biological activity of class A toxins has been ex- 
tended in [23,24], in which the crystal structures of 
V [23] and aconitine (A) [24] were determined. The 
positions of the nitrogens as well as the oxygen 
triads in BTX and V were matched and it was 
noted that the conformation of A may be changed 
on protonation as in the case of jesaconitine per- 
chlorate [25,26]. The structural studies under way 
[23] on grayanotoxin derivatives should help to 
understand the structural features required for the 
activity of class A toxins. The formula for w 
dihydroGTX II [2] and a possible structure for the 
ammonium ion complex are shown in fig.3. The 
structures of aconitine [3] and veratridine [4] are 
given in fig.4; the probable oxygen triad atoms are 
starred. 
The oxygen-oxygen distances for the triads 
selec_ted in (23,241 are shown in fig.5. Hydrogen 
bonding of an ammonium ion would presumably 
involve at least two of the oxygens in a triad. Given 
a range of N-H+ . . .O (hydrogen bond) distances 
between 2.50 and 3.00 A [ 151, a tetrahedral HNH 
angle of lOgo28 ’ and straight hydrogen bonds, the 
O-O distances should be between 4.1 and 4.9 A. 
Only one of the distances in the oxygen triad is 
consistently within that range. The ‘envelope of 
opportunity’ (the volume within which the E- 
ammonium ion may associate with the triad ox- 
ygens) must be differently shaped than that for the 
* 
Fig.3. The formula for a-dihydroGTX II (2) along with 
a plausible structure for the ammonium complex of the 
toxin (ammonium ion-oxygen triad complex). 
CH3b CHzOCH3 
C,H3 
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Fig.4. Structures of: (a) aconitine (3) and (b) veratridine 
(4) are shown with the oxygen triad atoms starred. 
crown ethers (O-O distances of 4.82 A [15]) and 
would involve a bent hydrogen bond. 
Strong support for the energetically favorable 
nature of ammonium ion complexation with a 
triad of oxygen atoms comes from the ther- 
mochemical studies of Meot-Ner [27] on gas-phase 
complexes of ammonium ions with ethers and 
18-crown-6. The binding to the crown compound 
may be as much as 21 kcal/mol more than that to 
an ether reflecting the energetic advantage accrue- 
ing to multiple bonding. The implications for toxin 
action are profound and worthy of further ex- 
o 4.22@),4.78(BTX) --____-_____ 
\\ 4.89(A) ? 
2.72(V) / 2.34(V) 
2.9O(BTX) \ 
4.54(A) \ 
/ 2.26(BTX) 
\ / 
/ 2.90(A) 
Fig.5. The oxygen-oxygen distances within oxygen 
triads of the toxins batrachotoxin (BTX), aconitine (A) 
and veratridine (V) [23]. 
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ploration in view of the occurrence of oxygen 
triads in ionophores. 
Class B toxins act at a site different from that of 
class A toxins as shown by synergy with the class 
A toxins, V [28] and BTX [29]. The lipid soluble 
class A toxins may act on the cytoplasmic side of 
the channel [30], whereas class B toxins probably 
act on the extracellular side of the channel. 
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